|
Market Closed -
Other stock markets
|
After hours 20:00:00 | |||
| 252.86 USD | -2.14% |
|
254.18 | +0.52% |
| 07-31 | Jazz Pharmaceuticals Has Several Growth Options Beyond Marketed Drugs, RBC Says | MT |
| 07-17 | Canaccord Genuity Initiates Coverage on Jazz Pharmaceuticals With Buy Rating, $290 Price Target | MT |
| Market Cap | 15.88B 13.81B 12.85B 11.8B 22.28B 1,516B 22.63B 151B 59.46B 755B 59.65B 58.34B 2,531B | P/E 2026 * |
17.9x | P/E 2027 * | 16.2x |
|---|---|---|---|---|---|
| Enterprise Value | 17.58B 15.28B 14.23B 13.06B 24.67B 1,678B 25.05B 168B 65.81B 836B 66.03B 64.58B 2,802B | EV / Sales 2026 * |
3.9x | EV / Sales 2027 * | 3.28x |
| Free-Float |
96.66% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Jazz Pharmaceuticals plc
| 1 day | -2.14% | ||
| 1 week | -0.40% | ||
| 1 month | +4.93% | ||
| 3 months | +24.55% | ||
| 6 months | +53.72% | ||
| Current year | +48.74% |
| 1 week | 250.71 |  | 261.3 |
| 1 month | 233.46 | | 261.3 |
| Current year | 156.95 | | 261.3 |
| 1 year | 105 | | 261.3 |
| 3 years | 95.49 | | 261.3 |
| 5 years | 95.49 | | 261.3 |
| 10 years | 86.88 | | 261.3 |
| Manager | Title | Age | Since |
|---|---|---|---|
Renée Galá
CEO | Chief Executive Officer | 54 | 2025-08-10 |
Philip Johnson
DFI | Director of Finance/CFO | 62 | 2024-02-29 |
Mary Henderson
CTO | Chief Tech/Sci/R&D Officer | 54 | 2023-07-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Bruce Cozadd
CHM | Chairman | 62 | 2003-02-28 |
Seamus Mulligan
BRD | Director/Board Member | 65 | 2012-01-17 |
Rick Winningham
BRD | Director/Board Member | 66 | 2009-12-31 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 7/1/26 | Sell | Founder | -6,000 | 0.0096% | ||
| 6/30/26 | Tax | Executive/Senior Manager | -2,527 | 0.0040% | ||
| 6/30/26 | Tax | Chief Executive Officer | -4,835 | 0.0077% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -2.14% | -0.40% | +120.59% | +93.88% | 15.88B | |
| -0.53% | -3.95% | +55.23% | +152.74% | 1,024B | |
| +0.21% | -2.68% | +55.61% | +53.02% | 618B | |
| -2.51% | -3.25% | +32.76% | +67.76% | 443B | |
| +0.06% | -0.42% | +37.53% | +30.67% | 349B | |
| -0.14% | -0.24% | +34.41% | +39.01% | 297B | |
| -0.69% | -0.30% | +11.55% | +12.93% | 264B | |
| -7.37% | -4.40% | -2.54% | -43.87% | 209B | |
| -0.64% | +2.43% | +30.52% | +64.49% | 208B | |
| -0.82% | +0.70% | +15.96% | +71.01% | 162B | |
| Average | -1.46% | -1.12% | +39.16% | +54.16% | 358.96B | |
| Weighted average by Cap. | -0.99% | -1.93% | +39.60% | +73.05% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 4.51B 3.92B 3.65B 3.35B 6.33B 431B 6.43B 43.03B 16.89B 214B 16.94B 16.57B 719B | 4.84B 4.21B 3.92B 3.6B 6.79B 462B 6.9B 46.17B 18.12B 230B 18.18B 17.78B 771B |
| Net income | 1.02B 889M 828M 760M 1.44B 97.65B 1.46B 9.76B 3.83B 48.61B 3.84B 3.76B 163B | 1.07B 928M 864M 793M 1.5B 102B 1.52B 10.18B 4B 50.73B 4.01B 3.92B 170B |
| Net Debt | 1.7B 1.48B 1.37B 1.26B 2.38B 162B 2.42B 16.2B 6.36B 80.71B 6.38B 6.24B 271B | 15.43M 13.41M 12.48M 11.46M 21.64M 1.47B 21.98M 147M 57.75M 733M 57.94M 56.67M 2.46B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-07-31 | US$252.86 | -2.14% | 572,977 |
| 26-07-30 | US$258.38 | +0.94% | 728,859 |
| 26-07-29 | US$255.97 | -0.37% | 622,706 |
| 26-07-28 | US$256.92 | +0.58% | 945,212 |
| 26-07-27 | US$255.43 | +0.61% | 771,878 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- JAZZ Stock
Select your edition
All financial news and data tailored to specific country editions
